Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
+38.3%/yr
vs +158.6%/yr prior
5Y CAGR
+70.2%/yr
Recent deceleration
Acceleration
-120.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
14.3x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $291.85M | +43.7% |
| 2024 | $203.07M | +23.9% |
| 2023 | $163.91M | +48.7% |
| 2022 | $110.25M | +122.3% |
| 2021 | $49.59M | +142.7% |
| 2020 | $20.43M | +650.7% |
| 2019 | $2.72M | +10.4% |
| 2018 | $2.46M | +58.4% |
| 2017 | $1.56M | +44.7% |
| 2016 | $1.07M | - |